N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein B secretion

Details for Australian Patent Application No. 2003250215 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Roevens, Peter Walter Maria; Backx, Leo Jacobus Jozef; Meerpoel, Lieven

Agent Shelston IP

Pub. Number AU-B-2003250215

PCT Number PCT/EP03/08694

PCT Pub. Number WO2004/017969

Priority 02078309.8 12.08.02 EP

Filing date 5 August 2003

Wipo publication date 11 March 2004

Acceptance publication date 22 January 2009

International Classifications

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07D 211/34 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/62 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

16 October 2003 Complete Application Filed

  Priority application(s): 02078309.8 12.08.02 EP

22 April 2004 Application Open to Public Inspection

  Published as AU-B-2003250215

22 January 2009 Application Accepted

  Published as AU-B-2003250215

21 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003250216-IL-7 drug substance, IL7 comprising composition, preparation and uses thereof

2003250214-METHOD FOR PRODUCING PHTHALIC ACID DICHLORIDE